Mankind Pharma Ltd.'s market cap is currently ₹968.22B. The company's EPS TTM is ₹50.915; its P/E ratio is 45.70; Mankind Pharma Ltd. is scheduled to report earnings on January 23, 2025, and the estimated EPS forecast is ₹13.30. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	₹ 103.35B	₹ 87.43B	₹ 77.82B	₹ 62.14B	₹ 58.65B
Gross Profit	₹ 70.66B	₹ 33.88B	₹ 53.12B	₹ 43.89B	₹ 39.42B
Operating Income	₹ 40.87B	₹ 16.18B	₹ 19.23B	₹ 16.66B	₹ 15.14B
EBITDA	₹ 28.09B	₹ 20.27B	₹ 21.47B	₹ 18.17B	₹ 15.41B
Net Income	₹ 19.13B	₹ 12.82B	₹ 14.33B	₹ 12.65B	₹ 10.30B
Balance Sheet
Cash & Short-Term Investments	₹ 33.86B	₹ 15.29B	₹ 12.79B	₹ 20.04B	₹ 10.84B
Total Assets	₹ 119.63B	₹ 97.15B	₹ 91.48B	₹ 63.73B	₹ 50.73B
Total Debt	₹ 2.07B	₹ 1.70B	₹ 8.73B	₹ 2.41B	₹ 1.31B
Net Debt	₹ -1.75B	₹ -1.34B	₹ 5.71B	₹ 734.77M	₹ -951.93M
Total Liabilities	₹ 23.87B	₹ 20.67B	₹ 28.31B	₹ 15.10B	₹ 14.02B
Stockholders' Equity	₹ 93.63B	₹ 74.35B	₹ 61.55B	₹ 47.22B	₹ 34.85B
Cash Flow
Free Cash Flow	₹ 17.70B	₹ 9.53B	₹ -14.26B	₹ 8.25B	₹ 8.42B
Operating Cash Flow	₹ 21.52B	₹ 17.85B	₹ 9.20B	₹ 11.37B	₹ 10.70B
Investing Cash Flow	₹ -20.82B	₹ -10.67B	₹ -13.69B	₹ -12.22B	₹ -4.39B
Financing Cash Flow	₹ 52.66M	₹ -6.98B	₹ 6.05B	₹ -78.11M	₹ -5.31B

Currency in INR

Mankind Pharma Ltd. Earnings and Revenue History

Income Statement >

Mankind Pharma Ltd. Debt to Assets

Balance Sheet >

Mankind Pharma Ltd. Cash Flow

Cash Flow >

Mankind Pharma Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing